Medicaid Managed Care and Wegovy: Why Your Plan Often Doesn't Set the GLP-1 Rule

A Medicaid managed care plan covers Wegovy for weight loss only if your state’s Medicaid program does, and in most states the plan does not write the rule itself. Federal rules require a plan to cover services at least as fully as fee-for-service Medicaid and to meet the same federal drug-coverage standards the state must meet, and many states go further by making every plan use one state drug list or by running the drug benefit outside the plans entirely.^[2][3] Where a state leaves room, plans can attach their own criteria, so two plans in the same state can approve the same prescription on different terms.^[10][11][12] This matters for most people on Medicaid: 84.8% of enrollees got some or all of their care through a managed care plan as of July 2024.^[1]

What is the difference between Medicaid managed care and fee-for-service?

In fee-for-service Medicaid, the state pays pharmacies directly and applies its own preferred drug list and prior authorization criteria. In managed care, the state pays a private health plan a monthly amount per member, and the plan pays for care. The plan’s name is usually printed on your card. Comprehensive managed care plans covered 67.9 million people in 2024, down from 76.4 million in 2023 as states rechecked eligibility after the pandemic.^[1]

For GLP‑1 drugs, the first rule sits above both systems. Federal law puts drugs given to lose or gain weight on a short list of uses a state may leave out of Medicaid.^[4] A state that leaves weight loss out removes it for fee-for-service and managed care members alike. Our pages on Medicaid and Wegovy and Medicaid and Zepbound cover that exclusion and the heart, liver and sleep apnea approvals that fall outside it.

Can a Medicaid health plan refuse a drug the state covers?

Not on its own terms. A state’s contract with a plan must require services in an amount, duration and scope no less than fee-for-service Medicaid provides, and the plan’s definition of medical necessity can be no more restrictive than the state’s.^[2] For drugs, the rules are more specific. A plan that covers outpatient drugs must meet the federal Medicaid drug standards “as if such standards applied directly” to it, run a drug utilization review program, and operate prior authorization under the same federal timing rule the state follows.^[3]

That timing rule is short. Under federal law, Medicaid may require prior approval of a drug only if the system answers within 24 hours of a request, and it must provide at least a 72-hour emergency supply.^[4] There is a catch for weight-loss drugs: the emergency-supply guarantee does not extend to the categories a state may exclude, which include weight loss.^[4]

A plan can still be stricter in practice wherever the state leaves room for plan-level criteria, as long as the result stays within the state’s coverage. If a plan denies a drug the state plan covers for your condition, that gap is the core of an appeal.

Can a plan cover Wegovy for weight loss when the state does not?

Federal rules give plans room to cover services beyond the state plan voluntarily, but the cost of those extras cannot be counted when the state sets the plan’s payment rates.^[3] In other words, a plan that chose to pay for weight-loss GLP‑1s in an excluding state would pay out of its own margin. In the plan documents read for this article, plans carried the state’s exclusion forward instead. Both of the District of Columbia’s plans write it into their criteria: AmeriHealth Caritas DC excludes requests for “weight reduction and maintenance for overweight or obesity,” and MedStar Family Choice DC states that Zepbound “cannot be approved for indication of weight management.”^[11][12]

How do states run the drug benefit in managed care?

States have settled on a few arrangements, and the one your state uses tells you whose document to read. These examples come from each state’s own current documents.

New York and California show the carve-out at full scale. In New York, mainstream managed care members have received their drugs through the state’s fee-for-service program since April 1, 2023, with managed long-term care plans left out of the change.^[5] California’s Medi-Cal Rx took over pharmacy claims and prior authorization from the state’s plans on January 1, 2022.^[6] In either state, the plan on your card has no say over a GLP‑1 prescription filled at a pharmacy. Our New York Medicaid guide reads the NYRx criteria.

Ohio and Indiana keep plans in place but take the drug decision out of their hands. Ohio’s October 2026 list is titled for “Medicaid Fee-for-Service and Managed Care Plans,” and it lists Wegovy only under GLP‑1 drugs for non-obesity uses, such as lowering heart risk.^[7] Indiana’s list applies to fee-for-service and managed care claims alike and repeats the state rule that excludes any drug used to promote weight loss.^[8] Switching plans in either state will not open a weight-loss route.

North Carolina covers weight-loss GLP‑1s and spells out the limit on plans. Its October 2026 drug list prefers Wegovy, Wegovy HD, Foundayo and the Zepbound pen and KwikPen in the obesity class, applies state clinical criteria, and forbids the health plans to layer their own approval rules or other limits on top of them.^[9] The same list records that the Zepbound vial was removed effective September 4, 2026.^[9] Our North Carolina guide covers the criteria themselves.

Why can two Medicaid plans in one state give different answers?

Where the state leaves room for plan-level rules, the differences can be real. Virginia’s drug list applies to fee-for-service and to managed care members who are not also on Medicare, but the state notes that a managed care plan “may utilize different guidelines” than those it describes for fee-for-service.^[10]

The District of Columbia shows what that looks like. Both of its plans exclude weight loss and both cover Zepbound for obstructive sleep apnea, but the renewal tests differ. AmeriHealth Caritas DC approves a first request for six months and renewals for twelve, and to renew it wants a better sleep score or fewer symptoms, at least 80% of fills picked up on time, and a weight loss of at least 5%.^[11] MedStar Family Choice DC approves six months at a time, refuses renewal when BMI falls below 30, and asks for a repeat sleep study once treatment passes twelve months.^[12] AmeriHealth also sets a minimum age of 45 for Wegovy to lower heart risk.^[11] Our DC Medicaid guide sets the two plans side by side.

How fast must a Medicaid plan decide a GLP-1 prior authorization?

Drug requests run on their own clock. For most services, a plan must decide a standard request within 7 calendar days for contract periods starting on or after January 1, 2026, and an urgent one within 72 hours.^[2] For outpatient drugs, the regulation points instead to the 24-hour response rule in the Medicaid drug statute.^[2][4] CMS’s 2024 prior authorization rule, which set the 72-hour and seven-day limits for medical services, says plainly that it “does not apply to prior authorization decisions for drugs.”^[13] If a GLP‑1 request sits for a week with no answer, ask the plan when it received it and when it responded.

What does research show about Medicaid GLP-1 denials?

A national claims study of first GLP‑1 prescriptions from 2018 to 2024 found denial rates of 12.6% in Medicaid against 5.6% in commercial coverage, and 16.8% for obesity-labeled brands against 6.3% for diabetes brands. Only 34.1% of people whose first claim was denied got a paid fill within 90 days.^[14] A separate analysis of state Medicaid drug data found that 13 states covered GLP‑1s for obesity as of August 2024 and that GLP‑1 prescribing ran higher among managed care members than among fee-for-service members.^[15] Both are observational studies that describe patterns, not why any single claim was denied.

State-mandated lists carry trade-offs that researchers have measured outside GLP‑1s. A 2018 study by pharmacy benefit manager employees compared a Florida Medicaid plan after the state required a single list with a plan in another state. Overall drug use in the Florida plan fell 6% more and plan drug costs rose 27% more than in the comparison plan.^[16] It covered one plan and one year after the change, and the authors’ employer manages drug benefits.

How do I find out which rules apply to my Medicaid plan?

1. Read your card. A plan name usually means managed care; a state agency name alone usually means fee-for-service. In a carve-out state the pharmacy section of the card may name the state program.
2. Ask the plan one question: does it use the state’s preferred drug list and criteria for GLP‑1s, or its own? Ask for the criteria document by name.
3. Check the use, not just the drug. If your state excludes weight loss, ask whether the plan covers Wegovy for heart-risk reduction or MASH, or Zepbound for sleep apnea. Our Medicaid coverage overview lists what each approval requires.
4. Appeal on time. A plan must decide a standard appeal within 30 calendar days and an urgent one within 72 hours. If it upholds the denial, or misses its own deadlines, you can ask for a state fair hearing.^[17] Our guide to prior authorization and appeals covers the letters and deadlines.
5. Compare plans at your next chance to switch. Where a state limits plan changes, you can still switch without a reason within 90 days of joining and at least once every 12 months after that.^[18] In a uniform-list or carve-out state, switching will not change a GLP‑1 answer.